{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-239277","form_type":"8-K","ticker":"ASMB","cik":"0001426800","company_name":"ASSEMBLY BIOSCIENCES, INC.","filed_at":"2026-05-26T20:10:16+00:00","discovered_at":"2026-05-26T20:11:00.385817+00:00","generated_at":"2026-05-26T20:14:11.107921+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"confidence":"high","headline":"Assembly Biosciences raises $115M gross in underwritten equity offering; underwriters exercise option in full","bullets":["Closed offering of 3,924,624 common shares at $26.50 and pre-funded warrants for 415,000 shares at $26.499.","Net proceeds of approximately $107.4M after underwriting discounts and estimated expenses.","Investors include Gilead Sciences, Commodore Capital, Farallon Capital, and others.","Proceeds to fund clinical development of pipeline candidates and for general corporate purposes.","Underwriters' 30-day option for 566,040 additional shares exercised in full on May 22."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-239277","json":"https://secwatch.observer/filing/0001193125-26-239277.json","markdown":"https://secwatch.observer/filing/0001193125-26-239277.md","text":"https://secwatch.observer/filing/0001193125-26-239277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526239277/0001193125-26-239277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526239277/asmb-20260521.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T20:14:11.107921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}